Factors Secreted by Endothelial Progenitor Cells Enhance Neurorepair Responses after Cerebral Ischemia in Mice

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Rosell, Anna ^a   Morancho, Anna ^a   Navarro Sobrino, Miriam ^a   Martínez Saez, Elena ^b   Hernández Guillamon, Mar ^a   Lope Piedrafita, Silvia ^a,c   Barceló, Verónica ^a   Borrás, Francesc ^b   Penalba, Anna ^a   García Bonilla, Lidia ^a   Montaner, Joan ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR B; GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR BB; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; CAPILLARY DENSITY; CELL MIGRATION; CELL THERAPY; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; FORELIMB; HISTOPATHOLOGY; MALE; MOUSE; MUSCLE STRENGTH; NERVE FIBER; NERVOUS SYSTEM DEVELOPMENT; NEUROBLAST; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTEIN SECRETION; TISSUE REPAIR;

ANIMALS; AXONS; BRAIN; BRAIN ISCHEMIA; CELL MOVEMENT; CELL- AND TISSUE-BASED THERAPY; CULTURE MEDIA, CONDITIONED; ENDOTHELIAL CELLS; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICE, INBRED BALB C; NEOVASCULARIZATION, PHYSIOLOGIC; STEM CELLS; STROKE; TREATMENT OUTCOME;

EID: 84883425820     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0073244     Document Type: Article

References (35)

1. Molina CA (2011) Reperfusion therapies for acute ischemic stroke: current pharmacological and mechanical approaches. Stroke 42(1 Suppl): S16-19.
2. Carmichael ST, (2008) Themes and strategies for studying the biology of stroke recovery in the poststroke epoch. Stroke 39: 1380-1388.
3. Shen Q, Goderie SK, Jin L, Karanth N, Sun Y, et al. (2004) Endothelial cells stimulate self-renewal and expand neurogenesis of neural stem cells. Science 304: 1338-1340.
4. Ohab JJ, Fleming S, Blesch A, Carmichael ST, (2006) A neurovascular niche for neurogenesis after stroke. J Neurosci. 26: 13007-13016.
5. Pepper MS, (1997) Manipulating angiogenesis. From basic science to the bedside. Arterioscler Thromb Vasc Biol 17: 605-619.
6. Asahara T, Murohara T, Sullivan A, Silver, M; van der Zee R, et al. (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 964-967.
7. Taguchi A, Soma T, Tanaka H, Kanda T, Nishimura H, et al. (2004) Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J Clin Invest 114: 330-338.
8. Ohta T, Kikuta K, Imamura H, Takagi Y, Nishimura M, et al. (2006) Administration of ex vivo-expanded bone marrow-derived endothelial progenitor cells attenuates focal cerebral ischemia reperfusion injury in rats. Neurosurgery 59: 679-686.
9. Moubarik C, Guillet B, Youssef B, Codaccioni JL, Piercecchi MD, et al. (2011) Transplanted Late Outgrowth Endothelial Progenitor Cells as Cell Therapy Product for Stroke. Stem Cell Rev 7: 208-220.
10. Fan Y, Shen F, Frenzel T, Zhu W, Ye J, et al. (2010) Endothelial progenitor cell transplantation improves long-term stroke outcome in mice. Ann Neurol 67: 488-497.
11. Lodi D, Iannitti T, Palmieri B, (2011) Stem cells in clinical practice: applications and warnings. J Exp Clin Cancer Res 30: 9.
12. Seminatore C, Polentes J, Ellman D, Kozubenko N, Itier V, et al. (2010) The postischemic environment differentially impacts teratoma or tumor formation after transplantation of human embryonic stem cell-derived neural progenitors. Stroke 41: 153-159.
13. Yang Z, Di Santo S, Kalka C, (2010) Current developments in the use of stem cell for therapeutic neovascularisation: is the future therapy "cell-free"? Swiss Med Wkly 140: w13130.
14. Rosell A, Arai K, Lok J, He T, Guo S, et al. (2009) Interleukin-1beta augments angiogenic responses of murine endothelial progenitor cells in vitro. J Cereb Blood Flow Metab 29: 933-943.
15. Morancho A, García-Bonilla L, Barceló V, Giralt D, Campos-Martorell M, et al. (2012) A new method for focal transient cerebral ischemia by distal compression of the middle cerebral artery. Neuropathol Appl Neurobiol 38: 617-627.
16. Le Bihan D, Mangin JF, Poupon C, Clark CA, Pappata S, et al. (2001) Diffusion tensor imaging: concepts and applications. J Magn Reson Imaging 13: 534-546.
17. Jiang Q, Zhang ZG, Ding GL, Silver B, Zhang L, et al. (2006) MRI detects white matter reorganization after neural progenitor cell treatment of stroke. Neuroimage 32: 1080-1089.
18. Liu HS, Shen H, Harvey BK, Castillo P, Lu H, et al. (2011) Post-treatment with amphetamine enhances reinnervation of the ipsilateral side cortex in stroke rats. Neuroimage 56: 280-289.
19. Yanamoto H, Hong SC, Soleau S, Kassell NF, Lee KS, (1996) Mild postischemic hypothermia limits cerebral injury following transient focal ischemia in rat neocortex. Brain Res 718: 207-211.
20. Guo Q, Wang G, Liu X, Namura S, (2009) Effects of gemfibrozil on outcome after permanent middle cerebral artery occlusion in mice. Brain Res 1279: 121-130.
21. Rosell A, Agin V, Rahman M, Morancho A, Ali C, et al. (2013) Distal occlusion of the middle cerebral artery in mice: Are we ready to assess long-term functional outcome? Transl Stroke Res 4: 297-307.
22. Kondziolka D, Steinberg GK, Wechsler L, Meltzer CC, Elder E, et al. (2005) Neurotransplantation for patients with subcortical motor stroke: a phase 2 randomized trial. J Neurosurg 103: 38-45.
23. Bang OY, Lee JS, Lee PH, Lee G, (2005) Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol 57: 874-882.
24. Moniche F, Gonzalez A, Gonzalez-Marcos JR, Carmona M, Piñero P, et al. (2012) Intra-arterial bone marrow mononuclear cells in ischemic stroke: a pilot clinical trial. Stroke 43: 2242-2244.
25. Battistella V, de Freitas GR, da Fonseca LM, Mercante D, Gutfilen B, et al. (2001) Safety of autologous bone marrow mononuclear cell transplantation in patients with nonacute ischemic stroke. Regen Med 6: 45-52.
26. Hayakawa K, Pham LD, Katusic ZS, Arai K, Lo EH, (2012) Astrocytic high-mobility group box 1 promotes endothelial progenitor cell-mediated neurovascular remodeling during stroke recovery. Proc Natl Acad Sci U S A 109: 7505-7510.
27. Ward NL, Moore E, Noon K, Spassil N, Keenan E, et al. (2007) Cerebral angiogenic factors, angiogenesis, and physiological response to chronic hypoxia differ among four commonly used mouse strains. J Appl Physiol 102: 1927-1935.
28. Zhang ZG, Zhang L, Jiang Q, Zhang R, Davies K, et al. (2000) VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J Clin Invest 106: 829-838.
29. Shimamura M, Sato N, Oshima K, Aoki M, Kurinami H, et al. (2004) Novel therapeutic strategy to treat brain ischemia: overexpression of hepatocyte growth factor gene reduced ischemic injury without cerebral edema in rat model. Circulation 10: 424-431.
30. Di Santo S, Yang Z, Wyler von Ballmoos M, Voelzmann J, Diehm N, et al. (2009) Novel cell-free strategy for therapeutic angiogenesis: in vitro generated conditioned medium can replace progenitor cell transplantation. PLoS One 4: e5643.
31. Kim JY, Song SH, Kim KL, Ko JJ, Im JE, et al. (2010) Human cord blood-derived endothelial progenitor cells and their conditioned media exhibit therapeutic equivalence for diabetic wound healing. Cell Transplant 19: 1635-1644.
32. Navarro-Sobrino M, Rosell A, Hernández-Guillamon M, Penalba A, Ribó M, et al. (2010) Mobilization, endothelial differentiation and functional capacity of endothelial progenitor cells after ischemic stroke. Microvasc Res 80: 317-323.
33. Ohab JJ, Carmichael ST, (2008) Poststroke neurogenesis: emerging principles of migration and localization of immature neurons. Neuroscientist 14: 369-380.
34. Andres RH, Horie N, Slikker W, Keren-Gill H, Zhan K, et al. (2011) Human neural stem cells enhance structural plasticity and axonal transport in the ischaemic brain. Brain 134: 1777-1789.
35. Horie N, Pereira MP, Niizuma K, Sun G, Keren-Gill H, et al. (2011) Transplanted stem cell-secreted vascular endothelial growth factor effects poststroke recovery, inflammation, and vascular repair. Stem Cells 29: 274-285.